$1.16
-0.01-0.85%
At close: -
$1.16
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Erasca Analyst Ratings and Price Targets | NASDAQ:ERAS | Benzinga
Erasca Inc has a consensus price target of $6.11 based on the ratings of 9 analysts. The high is $11 issued by Evercore ISI Group on June 6, 2023. The low is $3 issued by Goldman Sachs on March 21, 2025. The 3 most-recent analyst ratings were released by Raymond James, Goldman Sachs, and HC Wainwright & Co. on March 26, 2025, March 21, 2025, and March 21, 2025, respectively. With an average price target of $4.67 between Raymond James, Goldman Sachs, and HC Wainwright & Co., there's an implied 302.30% upside for Erasca Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Raymond James
Goldman Sachs
HC Wainwright & Co.
Morgan Stanley
B of A Securities
1calculated from analyst ratings
Analyst Ratings for Erasca
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/26/2025 | Buy Now | 331.03% | Raymond James | Laura Prendergast19% | → $5 | Initiates | → Outperform | Get Alert |
| 03/21/2025 | Buy Now | 158.62% | Goldman Sachs | Chris Shibutani55% | $3.5 → $3 | Maintains | Buy | Get Alert |
| 03/21/2025 | Buy Now | 417.24% | HC Wainwright & Co. | Andres Maldonado41% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2025 | Buy Now | 244.83% | Morgan Stanley | Jeffrey Hung50% | $4 → $4 | Assumes | → Overweight | Get Alert |
| 01/07/2025 | Buy Now | 331.03% | B of A Securities | Alec Stranahan33% | $5 → $5 | Upgrade | Neutral → Buy | Get Alert |
| 11/18/2024 | Buy Now | 417.24% | Jefferies | Maury Raycroft31% | → $6 | Initiates | → Buy | Get Alert |
| 11/13/2024 | Buy Now | 417.24% | HC Wainwright & Co. | Andres Maldonado41% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 10/25/2024 | Buy Now | 201.72% | Goldman Sachs | Chris Shibutani55% | $3 → $3.5 | Maintains | Buy | Get Alert |
| 10/25/2024 | Buy Now | 417.24% | HC Wainwright & Co. | Andres Maldonado41% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2024 | Buy Now | 158.62% | Goldman Sachs | Chris Shibutani55% | $4 → $3 | Maintains | Buy | Get Alert |
| 08/13/2024 | Buy Now | 417.24% | HC Wainwright & Co. | Andres Maldonado41% | $5 → $6 | Maintains | Buy | Get Alert |
| 05/28/2024 | Buy Now | 244.83% | Goldman Sachs | Chris Shibutani55% | $7 → $4 | Maintains | Buy | Get Alert |
| 05/20/2024 | Buy Now | 331.03% | HC Wainwright & Co. | Andres Maldonado41% | $8 → $5 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 589.66% | HC Wainwright & Co. | Andres Maldonado41% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 04/02/2024 | Buy Now | 503.45% | Goldman Sachs | Chris Shibutani55% | $6 → $7 | Maintains | Buy | Get Alert |
| 03/28/2024 | Buy Now | 589.66% | HC Wainwright & Co. | Andres Maldonado41% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 03/11/2024 | Buy Now | 589.66% | Capital One | Naureen Quibria19% | → $8 | Initiates | → Overweight | Get Alert |
| 01/05/2024 | Buy Now | 417.24% | B of A Securities | Alec Stranahan33% | $11 → $6 | Downgrade | Buy → Neutral | Get Alert |
| 11/29/2023 | Buy Now | 503.45% | Mizuho | Mara Goldstein56% | $8 → $7 | Maintains | Buy | Get Alert |
| 11/28/2023 | Buy Now | 589.66% | HC Wainwright & Co. | Andres Maldonado41% | $10 → $8 | Maintains | Buy | Get Alert |
| 10/11/2023 | Buy Now | 762.07% | HC Wainwright & Co. | Andres Maldonado41% | → $10 | Initiates | → Buy | Get Alert |
| 06/06/2023 | Buy Now | 848.28% | Evercore ISI Group | Josh Schimmer52% | $20 → $11 | Maintains | Outperform | Get Alert |
| 06/06/2023 | Buy Now | 589.66% | Mizuho | Mara Goldstein56% | $9 → $8 | Maintains | Buy | Get Alert |
| 05/16/2023 | Buy Now | 675.86% | Goldman Sachs | Chris Shibutani55% | $10 → $9 | Maintains | Buy | Get Alert |
| 03/30/2023 | Buy Now | 675.86% | Mizuho | Mara Goldstein56% | → $9 | Initiates | → Buy | Get Alert |
| 02/24/2023 | Buy Now | 762.07% | Goldman Sachs | Chris Shibutani55% | → $10 | Initiates | → Buy | Get Alert |
| 02/03/2023 | Buy Now | 1193.1% | Morgan Stanley | Jeffrey Hung50% | → $15 | Upgrade | Equal-Weight → Overweight | Get Alert |
FAQ
What is the target price for Erasca (ERAS) stock?
The latest price target for Erasca (NASDAQ:ERAS) was reported by Raymond James on March 26, 2025. The analyst firm set a price target for $5.00 expecting ERAS to rise to within 12 months (a possible 331.03% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Erasca (ERAS)?
The latest analyst rating for Erasca (NASDAQ:ERAS) was provided by Raymond James, and Erasca initiated their outperform rating.
When was the last upgrade for Erasca (ERAS)?
The last upgrade for Erasca Inc happened on January 7, 2025 when B of A Securities raised their price target to $5. B of A Securities previously had a neutral for Erasca Inc.
When was the last downgrade for Erasca (ERAS)?
The last downgrade for Erasca Inc happened on January 5, 2024 when B of A Securities changed their price target from $11 to $6 for Erasca Inc.
When is the next analyst rating going to be posted or updated for Erasca (ERAS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Erasca, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Erasca was filed on March 26, 2025 so you should expect the next rating to be made available sometime around March 26, 2026.
Is the Analyst Rating Erasca (ERAS) correct?
While ratings are subjective and will change, the latest Erasca (ERAS) rating was a initiated with a price target of $0.00 to $5.00. The current price Erasca (ERAS) is trading at is $1.16, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
